Clicky

Agile Therapeutics, Inc. (AGRX)

Description: Agile Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, a once-weekly contraceptive patch, which is in Phase III clinical development. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, a 28-day regimen, which provides a shortened hormone-free interval; and AG890, a levonorgestrel-only contraceptive patch for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.


Keywords: Pharmaceutical Drugs Organic Compounds Alcohol Clinical Development Transdermal Medroxyprogesterone Acetate Estrogen Estranes Hormonal Contraception Progestogens Sex Hormones

Home Page: www.agiletherapeutics.com

AGRX Technical Analysis

500 College Road East
Princeton, NJ 08540
United States
Phone: 609 683 1880


Officers

Name Title
Mr. Alfred F. Altomari Chairman & CEO
Mr. Geoffrey P. Gilmore Chief Admin. Officer
Dr. Paul Korner M.B.A., M.D. Sr. VP & Chief Medical Officer
Mr. Jason Butch Principal Financial Officer, VP & Chief Accounting Officer
Matthew Riley Head of Investor Relations & Corp. Communications
Mr. Robert G. Conway M.E. Chief Corp. Planning & Supply Chain Officer
Dr. Elizabeth Ijeoma Onyemelukwe Garner M.D., M.P.H. Consultant
Ms. Amy Welsh Chief Commercial Officer
Joseph D'Urso Controller
Dr. Kathryn MacFarlane Pharm.D. Advisor

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.2457
Price-to-Sales TTM: 0.9136
IPO Date: 2014-05-23
Fiscal Year End: December
Full Time Employees: 30
Back to stocks